Fat-Soluble Vitamins & Micronutrients: Vitamins A and E and Carotenoids
Serum beta-cryptoxanthin
On this Page
Table 2.6.a. Serum beta-cryptoxanthin: Total population
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for the total U.S. population aged 3 years and older, National Health and Nutrition Examination Survey, 2001–2002. |
|
Geometric mean
(95% conf. interval) |
Selected percentiles (95% conf. interval) |
Sample
|size |
|
10th |
50th |
90th |
Males and Females |
Total, 3 years and older |
7.51 |
(7.12-7.93) |
3.20 |
(3.00-3.50) |
7.50 |
(7.00-7.90) |
17.8 |
(16.5-19.2) |
8317 |
3–5 years |
9.43 |
(8.40-10.6) |
4.10 |
(3.30-5.50) |
9.00 |
(7.80-10.5) |
22.8 |
(18.3-27.8) |
427 |
6–11 years |
9.40 |
(8.71-10.2) |
4.60 |
(4.10-5.10) |
9.10 |
(8.20-10.1) |
20.0 |
(17.0-22.9) |
1006 |
12–19 years |
7.63 |
(7.20-8.09) |
3.70 |
(3.40-4.00) |
7.50 |
(7.00-8.00) |
15.8 |
(14.4-17.6) |
2199 |
20–39 years |
7.11 |
(6.57-7.69) |
3.10 |
(2.80-3.50) |
6.80 |
(6.30-7.50) |
17.1 |
(15.2-19.3) |
1707 |
40–59 years |
7.28 |
(6.75-7.86) |
3.00 |
(2.70-3.40) |
7.10 |
(6.70-7.80) |
17.4 |
(15.3-19.7) |
1459 |
60 years and older |
7.44 |
(6.84-8.09) |
2.80 |
(2.50-3.20) |
7.70 |
(7.00-8.30) |
18.6 |
(17.5-19.6) |
1519 |
Males |
Total, 3 years and older |
7.35 |
(6.96-7.77) |
3.14 |
(2.80-3.40) |
7.50 |
(6.90-7.90) |
17.1 |
(16.0-18.5) |
4032 |
3–5 years |
9.80 |
(8.43-11.4) |
4.20 |
(3.20-5.60) |
9.60 |
(7.90-11.8) |
22.8 |
(15.6-31.9) |
217 |
6–11 years |
9.63 |
(8.84-10.5) |
5.00 |
(4.10-5.50) |
9.30 |
(8.40-10.2) |
21.2 |
(16.5-25.9) |
503 |
12–19 years |
7.64 |
(7.14-8.19) |
3.70 |
(3.30-4.20) |
7.50 |
(7.00-8.10) |
15.5 |
(14.2-17.7) |
1085 |
20–39 years |
7.15 |
(6.49-7.88) |
3.20 |
(2.80-3.50) |
7.10 |
(6.10-8.00) |
16.8 |
(15.2-19.8) |
723 |
40–59 years |
6.98 |
(6.57-7.42) |
2.90 |
(2.50-3.30) |
7.00 |
(6.50-7.60) |
16.1 |
(14.6-18.5) |
756 |
60 years and older |
6.64 |
(6.02-7.31) |
2.40 |
(1.90-2.90) |
7.00 |
(6.00-7.60) |
16.7 |
(15.8-17.7) |
748 |
Females |
Total, 3 years and older |
7.67 |
(7.23-8.12) |
3.40 |
(3.10-3.50) |
7.50 |
(7.00-7.90) |
18.2 |
(16.7-19.7) |
4285 |
3–5 years |
9.07 |
(7.79-10.6) |
3.90 |
(3.00-5.30) |
8.20 |
(6.40-10.4) |
23.3 |
(17.3-32.1) |
210 |
6–11 years |
9.15 |
(8.21-10.2) |
4.30 |
(4.00-4.80) |
8.70 |
(7.80-10.7) |
18.4 |
(16.1-21.6) |
503 |
12–19 years |
7.61 |
(7.10-8.16) |
3.70 |
(3.40-4.00) |
7.50 |
(7.00-8.00) |
16.0 |
(14.3-17.5) |
1114 |
20–39 years |
7.07 |
(6.50-7.70) |
3.10 |
(2.60-3.50) |
6.70 |
(6.10-7.50) |
17.5 |
(14.6-19.6) |
984 |
40–59 years |
7.61 |
(6.88-8.43) |
3.10 |
(2.80-3.50) |
7.30 |
(6.70-8.10) |
18.5 |
(15.4-21.9) |
703 |
60 years and older |
8.10 |
(7.41-8.86) |
3.10 |
(2.70-3.50) |
8.20 |
(7.40-8.80) |
20.1 |
(18.1-22.7) |
771 |
Table 2.6.b. Serum beta-cryptoxanthin: Mexican Americans
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for Mexican Americans in the U.S. population aged 3 years and older, National Health and Nutrition Examination Survey, 2001–2002. |
|
Geometric mean
(95% conf. interval) |
Selected percentiles (95% conf. interval) |
Sample
size |
|
10th |
50th |
90th |
Males and Females |
Total, 3 years and older |
12.1 |
(11.1-13.1) |
5.10 |
(4.80-5.70) |
12.1 |
(10.8-13.5) |
27.1 |
(25.0-29.8) |
2114 |
3–5 years |
11.0 |
(9.50-12.8) |
5.20 |
(4.20-6.70) |
10.3 |
(9.10-12.3) |
23.6 |
(18.8-42.0) |
126 |
6–11 years |
11.9 |
(10.6-13.3) |
6.20 |
(5.30-7.10) |
11.1 |
(10.0-13.4) |
24.1 |
(19.9-28.7) |
290 |
12–19 years |
9.72 |
(9.07-10.4) |
4.80 |
(4.20-5.40) |
9.70 |
(9.00-10.5) |
19.8 |
(17.2-21.4) |
696 |
20–39 years |
13.4 |
(11.9-15.1) |
5.60 |
(4.90-6.80) |
14.0 |
(11.6-15.9) |
30.0 |
(26.9-33.7) |
460 |
40–59 years |
12.2 |
(10.4-14.3) |
4.70 |
(3.80-5.80) |
12.7 |
(10.4-15.2) |
27.3 |
(23.2-36.9) |
287 |
60 years and older |
11.0 |
(9.19-13.2) |
3.70 |
(3.20-4.50) |
11.1 |
(9.20-13.4) |
28.5 |
(21.2-37.1) |
255 |
Males |
Total, 3 years and older |
11.8 |
(10.7-13.1) |
5.20 |
(4.70-5.70) |
11.7 |
(10.4-13.4) |
26.6 |
(23.8-29.9) |
1018 |
3–5 years |
11.1 |
(8.25-14.8) |
5.50† |
(3.60-6.90) |
10.3 |
(6.80-15.9) |
22.8† |
(14.1-43.1) |
62 |
6–11 years |
11.6 |
(10.2-13.0) |
5.60 |
(4.90-7.20) |
10.9 |
(9.70-12.6) |
24.1 |
(19.9-28.7) |
140 |
12–19 years |
9.32 |
(8.39-10.4) |
4.70 |
(3.50-5.50) |
9.34 |
(8.10-10.8) |
18.5 |
(15.2-22.2) |
330 |
20–39 years |
12.9 |
(11.3-14.8) |
5.30 |
(4.80-7.00) |
13.4 |
(10.6-15.4) |
29.8 |
(24.1-35.1) |
213 |
40–59 years |
12.9 |
(10.7-15.6) |
5.10 |
(3.20-7.50) |
13.1 |
(9.70-18.4) |
28.7 |
(24.1-38.3) |
147 |
60 years and older |
9.87 |
(8.17-11.9) |
3.50 |
(2.40-4.40) |
10.8 |
(8.40-13.2) |
23.9 |
(16.7-37.1) |
126 |
Females |
Total, 3 years and older |
12.3 |
(11.4-13.3) |
5.30 |
(4.90-6.00) |
12.2 |
(10.9-13.9) |
27.7 |
(25.3-32.1) |
1096 |
3–5 years |
11.0 |
(9.59-12.6) |
4.70† |
(3.20-7.50) |
9.90 |
(7.70-12.7) |
25.7† |
(17.7-44.1) |
64 |
6–11 years |
12.2 |
(10.7-14.0) |
6.80 |
(5.30-7.30) |
11.4 |
(9.50-14.3) |
25.4 |
(19.1-28.8) |
150 |
12–19 years |
10.2 |
(9.61-10.8) |
5.10 |
(4.50-5.80) |
10.0 |
(9.40-10.7) |
20.8 |
(18.8-22.5) |
366 |
20–39 years |
13.9 |
(12.1-16.1) |
6.00 |
(4.80-7.10) |
14.6 |
(11.3-17.6) |
32.2 |
(26.1-37.6) |
247 |
40–59 years |
11.5 |
(9.71-13.7) |
4.50 |
(3.80-5.80) |
11.9 |
(10.1-13.8) |
26.5 |
(18.8-42.9) |
140 |
60 years and older |
12.0 |
(9.47-15.3) |
4.30 |
(3.20-6.10) |
11.7 |
(8.50-17.3) |
29.7 |
(21.2-43.4) |
129 |
† Estimate is subject to greater uncertainty due to small cell size. |
Table 2.6.c. Serum beta-cryptoxanthin: Non-Hispanic blacks
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic blacks in the U.S. population aged 3 years and older, National Health and Nutrition Examination Survey, 2001–2002. |
|
Geometric mean
(95% conf. interval) |
Selected percentiles (95% conf. interval) |
Sample
size |
|
10th |
50th |
90th |
Males and Females |
Total, 3 years and older |
8.13 |
(7.50-8.81) |
3.90 |
(3.40-4.20) |
7.90 |
(7.40-8.50) |
18.0 |
(15.7-20.7) |
1987 |
3–5 years |
10.9 |
(9.72-12.2) |
5.80 |
(5.30-6.30) |
10.2 |
(8.30-12.7) |
20.9 |
(16.7-23.5) |
128 |
6–11 years |
12.0 |
(10.7-13.4) |
6.50 |
(5.50-7.90) |
11.8 |
(9.90-13.9) |
23.0 |
(20.4-26.3) |
338 |
12–19 years |
8.94 |
(8.44-9.47) |
4.70 |
(4.40-5.10) |
8.80 |
(8.30-9.30) |
16.6 |
(14.9-17.6) |
670 |
20–39 years |
7.60 |
(6.69-8.63) |
4.00 |
(3.60-4.30) |
7.00 |
(6.20-8.20) |
15.4 |
(12.7-21.9) |
318 |
40–59 years |
6.79 |
(6.35-7.26) |
3.10 |
(2.90-3.50) |
6.60 |
(6.10-7.50) |
15.5 |
(13.2-18.8) |
290 |
60 years and older |
7.89 |
(6.22-10.0) |
3.00 |
(2.30-3.40) |
7.80 |
(5.70-10.2) |
20.5 |
(15.7-29.6) |
243 |
Males |
Total, 3 years and older |
8.26 |
(7.59-8.99) |
4.00 |
(3.50-4.30) |
8.10 |
(7.30-9.10) |
17.8 |
(15.7-20.4) |
982 |
3–5 years |
10.7 |
(9.29-12.3) |
5.90† |
(5.30-6.40) |
10.2 |
(8.70-12.6) |
20.1† |
(16.1-22.7) |
64 |
6–11 years |
12.7 |
(11.2-14.4) |
6.70 |
(5.60-8.30) |
12.8 |
(10.9-14.2) |
23.1 |
(18.6-30.9) |
174 |
12–19 years |
8.91 |
(8.29-9.58) |
5.00 |
(4.50-5.40) |
8.90 |
(8.20-9.30) |
16.3 |
(14.4-18.8) |
339 |
20–39 years |
8.00 |
(6.63-9.67) |
4.00 |
(2.80-5.00) |
7.80 |
(5.70-10.2) |
15.9 |
(13.9-21.9) |
132 |
40–59 years |
6.69 |
(6.09-7.34) |
3.30 |
(2.90-3.70) |
6.50 |
(5.80-7.30) |
14.8 |
(12.1-19.1) |
154 |
60 years and older |
7.02 |
(5.69-8.66) |
3.10 |
(2.20-3.50) |
6.80 |
(5.70-8.20) |
15.7 |
(9.30-27.1) |
119 |
Females |
Total, 3 years and older |
8.02 |
(7.38-8.73) |
3.70 |
(3.30-4.10) |
7.80 |
(7.20-8.30) |
18.0 |
(15.3-21.6) |
1005 |
3–5 years |
11.1 |
(9.30-13.2) |
5.60† |
(5.00-6.40) |
10.6 |
(7.70-14.9) |
20.9† |
(15.4-53.1) |
64 |
6–11 years |
11.3 |
(9.47-13.4) |
6.30 |
(4.40-7.70) |
11.0 |
(8.50-13.8) |
21.6 |
(14.7-28.4) |
164 |
12–19 years |
8.97 |
(8.48-9.49) |
4.60 |
(4.00-5.00) |
8.90 |
(8.60-9.80) |
17.0 |
(15.2-17.7) |
331 |
20–39 years |
7.33 |
(6.38-8.42) |
3.80 |
(3.40-4.30) |
6.30 |
(6.10-7.30) |
15.3 |
(10.8-24.6) |
186 |
40–59 years |
6.89 |
(6.31-7.52) |
3.20 |
(2.50-3.70) |
6.70 |
(5.90-7.80) |
16.1 |
(12.9-19.1) |
136 |
60 years and older |
8.55 |
(6.37-11.5) |
2.70 |
(2.30-4.10) |
8.80 |
(5.10-13.9) |
23.0 |
(16.5-34.7) |
124 |
† Estimate is subject to greater uncertainty due to small cell size. |
Table 2.6.d. Serum beta-cryptoxanthin: Non-Hispanic whites
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic whites in the U.S. population aged 3 years and older, National Health and Nutrition Examination Survey, 2001–2002. |
|
Geometric mean
(95% conf. interval) |
Selected percentiles (95% conf. interval) |
Sample
size |
|
10th |
50th |
90th |
Males and Females |
Total, 3 years and older |
6.84 |
(6.47-7.24) |
3.00 |
(2.70-3.30) |
6.80 |
(6.30-7.20) |
15.6 |
(14.6-16.9) |
3552 |
3–5 years |
8.53 |
(7.14-10.2) |
3.90 |
(2.80-5.50) |
7.90 |
(6.40-10.4) |
19.8 |
(14.4-31.9) |
130 |
6–11 years |
8.49 |
(7.67-9.38) |
4.20 |
(3.80-4.90) |
8.30 |
(7.40-9.10) |
16.6 |
(14.6-21.8) |
296 |
12–19 years |
6.87 |
(6.41-7.36) |
3.30 |
(2.80-3.80) |
6.60 |
(6.10-7.00) |
14.3 |
(12.5-16.6) |
651 |
20–39 years |
6.16 |
(5.63-6.73) |
2.90 |
(2.60-3.40) |
5.90 |
(5.40-6.50) |
13.3 |
(11.1-16.4) |
765 |
40–59 years |
6.87 |
(6.39-7.38) |
2.90 |
(2.70-3.30) |
6.80 |
(6.20-7.40) |
15.6 |
(13.9-18.0) |
770 |
60 years and older |
7.14 |
(6.56-7.76) |
2.70 |
(2.30-3.20) |
7.50 |
(6.70-8.10) |
17.6 |
(16.4-19.1) |
940 |
Males |
Total, 3 years and older |
6.64 |
(6.31-6.99) |
2.90 |
(2.60-3.30) |
6.50 |
(6.20-7.00) |
14.7 |
(13.8-16.1) |
1724 |
3–5 years |
9.29 |
(7.45-11.6) |
3.80† |
(2.20-6.10) |
8.90 |
(6.50-11.3) |
23.9† |
(12.1-56.4) |
72 |
6–11 years |
8.68 |
(7.70-9.77) |
4.10 |
(3.70-5.10) |
8.30 |
(7.40-9.20) |
18.4 |
(13.8-26.3) |
155 |
12–19 years |
6.80 |
(6.30-7.33) |
3.20 |
(2.80-3.60) |
6.60 |
(6.10-7.40) |
14.0 |
(11.8-16.6) |
318 |
20–39 years |
6.23 |
(5.54-7.01) |
3.10 |
(2.70-3.50) |
6.00 |
(5.40-6.70) |
13.3 |
(10.8-16.5) |
311 |
40–59 years |
6.50 |
(6.17-6.84) |
2.80 |
(2.35-3.30) |
6.50 |
(5.90-7.10) |
14.3 |
(12.5-16.0) |
402 |
60 years and older |
6.34 |
(5.77-6.96) |
2.10 |
(1.90-2.60) |
6.80 |
(5.70-7.60) |
16.2 |
(15.2-17.2) |
466 |
Females |
Total, 3 years and older |
7.04 |
(6.57-7.55) |
3.10 |
(2.90-3.40) |
6.80 |
(6.30-7.40) |
16.4 |
(14.8-18.4) |
1828 |
3–5 years |
7.73 |
(5.91-10.1) |
3.90† |
(2.00-5.70) |
7.10 |
(5.30-11.3) |
15.0† |
(11.7-33.0) |
58 |
6–11 years |
8.27 |
(6.92-9.87) |
4.10 |
(3.50-4.90) |
8.20 |
(6.40-10.9) |
15.4 |
(13.5-18.7) |
141 |
12–19 years |
6.93 |
(6.33-7.59) |
3.50 |
(3.00-4.00) |
6.60 |
(6.00-7.10) |
14.5 |
(12.7-16.9) |
333 |
20–39 years |
6.09 |
(5.54-6.70) |
2.80 |
(2.40-3.40) |
6.00 |
(5.40-6.60) |
13.5 |
(10.8-17.8) |
454 |
40–59 years |
7.29 |
(6.52-8.16) |
3.10 |
(2.90-3.70) |
7.00 |
(6.10-7.90) |
17.5 |
(13.5-22.2) |
368 |
60 years and older |
7.82 |
(7.06-8.66) |
3.20 |
(2.70-3.60) |
8.00 |
(7.30-8.60) |
19.5 |
(16.9-21.6) |
474 |
† Estimate is subject to greater uncertainty due to small cell size. |